| scholarly article | Q13442814 |
| P2093 | author name string | A C Collins | |
| M J Marks | |||
| S Wonnacott | |||
| E Wright | |||
| J A Spencer | |||
| S Kaiser | |||
| C G Sharples | |||
| P Whiteaker | |||
| M Washburn | |||
| T Gallagher | |||
| L Soliakov | |||
| P2860 | cites work | Human alpha 7 acetylcholine receptor: cloning of the alpha 7 subunit from the SH-SY5Y cell line and determination of pharmacological properties of native receptors and functional alpha 7 homomers expressed in Xenopus oocytes | Q24310036 |
| Comparative structure of human neuronal alpha 2-alpha 7 and beta 2-beta 4 nicotinic acetylcholine receptor subunits and functional expression of the alpha 2, alpha 3, alpha 4, alpha 7, beta 2, and beta 4 subunits | Q24318625 | ||
| Assembly of human neuronal nicotinic receptor alpha5 subunits with alpha3, beta2, and beta4 subunits | Q24321864 | ||
| A new alpha-conotoxin which targets alpha3beta2 nicotinic acetylcholine receptors | Q27732691 | ||
| A new generation of Ca2+ indicators with greatly improved fluorescence properties | Q27860793 | ||
| Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction | Q27860958 | ||
| A reporter mutation approach shows incorporation of the "orphan" subunit beta3 into a functional nicotinic receptor | Q28273472 | ||
| Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors h alpha 2 beta 2, h alpha 2 beta 4, h alpha 3 beta 2, h alpha 3 beta 4, h alpha 4 beta 2, h alpha 4 beta 4 and h alpha 7 expressed in Xenopus oocytes | Q28301363 | ||
| Identification of four classes of brain nicotinic receptors using beta2 mutant mice | Q28510911 | ||
| Beta 3: a new member of nicotinic acetylcholine receptor gene family is expressed in brain | Q28579734 | ||
| The neuronal alpha6 subunit forms functional heteromeric acetylcholine receptors in human transfected cells | Q32014770 | ||
| International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. | Q33650110 | ||
| Conus peptides targeted to specific nicotinic acetylcholine receptor subtypes | Q33953540 | ||
| Neuronal nicotinic receptor alpha 6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain | Q34409926 | ||
| Presynaptic nicotinic ACh receptors | Q34415708 | ||
| The heterocyclic substituted pyridine derivative (+/-)-2-(-3-pyridinyl)-1-azabicyclo[2.2.2]octane (RJR-2429): a selective ligand at nicotinic acetylcholine receptors | Q34459625 | ||
| Molecular and cellular aspects of nicotine abuse | Q40986707 | ||
| Nicotinic receptors in the development and modulation of CNS synapses. | Q41005061 | ||
| Agonist-induced up-regulation of alpha4beta2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition | Q41032740 | ||
| The cholinergic regulation of intracellular calcium in the human neuroblastoma, SH-SY5Y. | Q41653829 | ||
| Neuronal nicotinic acetylcholine receptors as targets for drug discovery | Q41685305 | ||
| Purification of L-[3H]nicotine eliminates low affinity binding | Q41863551 | ||
| Blockade of nicotinic receptor-mediated release of dopamine from striatal synaptosomes by chlorisondamine and other nicotinic antagonists administered in vitro | Q42146107 | ||
| Anatoxin-a-evoked [3H]dopamine release from rat striatal synaptosomes | Q42628490 | ||
| Nicotinic modulation of [3H]dopamine release from striatal synaptosomes: pharmacological characterisation | Q44063773 | ||
| Distribution of alpha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat. | Q44234396 | ||
| Pharmacological characterization of neuronal acetylcholine gated ion channel receptor-mediated hippocampal norepinephrine and striatal dopamine release from rat brain slices. | Q46004793 | ||
| Characterisation of the binding of [3H]methyllycaconitine: a new radioligand for labelling alpha 7-type neuronal nicotinic acetylcholine receptors | Q48203305 | ||
| Two pharmacologically distinct components of nicotinic receptor-mediated rubidium efflux in mouse brain require the beta2 subunit | Q48228603 | ||
| Nicotinic receptor function determined by stimulation of rubidium efflux from mouse brain synaptosomes | Q48338250 | ||
| alpha-bungarotoxin- and methyllycaconitine-sensitive nicotinic receptors mediate fast synaptic transmission in interneurons of rat hippocampal slices | Q48351279 | ||
| Nicotinic acetylcholine subunit mRNA expression in dopaminergic neurons of the rat substantia nigra and ventral tegmental area | Q48357665 | ||
| Synaptic potentials mediated via alpha-bungarotoxin-sensitive nicotinic acetylcholine receptors in rat hippocampal interneurons. | Q48380210 | ||
| Behavioural and ligand-binding studies in rats with 1-acetyl-4-methylpiperazine, a novel nicotinic agonist. | Q48390087 | ||
| Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons | Q48428303 | ||
| Characterization of nicotinic receptor-mediated [3H]dopamine release from synaptosomes prepared from mouse striatum | Q48434978 | ||
| Differential inhibition by alpha-conotoxin-MII of the nicotinic stimulation of [3H]dopamine release from rat striatal synaptosomes and slices. | Q48519029 | ||
| Alpha-conotoxin MII blocks nicotine-stimulated dopamine release in rat striatal synaptosomes. | Q48658270 | ||
| Pharmacological comparison of transient and persistent [3H]dopamine release from mouse striatal synaptosomes and response to chronic L-nicotine treatment | Q48671909 | ||
| Upregulation of surface alpha4beta2 nicotinic receptors is initiated by receptor desensitization after chronic exposure to nicotine | Q48915839 | ||
| Voltage-sensitive Ca2+ channels involved in nicotinic receptor-mediated [3H]dopamine release from rat striatal synaptosomes | Q71152133 | ||
| Nicotinic agonists differ in activation and desensitization of 86Rb+ efflux from mouse thalamic synaptosomes | Q71152676 | ||
| Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. III. Agonist actions of the novel alkaloid epibatidine and analysis of type II current | Q71705104 | ||
| Characterization of Nicotinic Acetylcholine Receptors Expressed by Cells of the SH-SY5Y Human Neuroblastoma Clonal Line | Q84900438 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dopamine | Q170304 |
| striatum | Q1319792 | ||
| P304 | page(s) | 2783-2791 | |
| P577 | publication date | 2000-04-01 | |
| P1433 | published in | Journal of Neuroscience | Q1709864 |
| P1476 | title | UB-165: a novel nicotinic agonist with subtype selectivity implicates the alpha4beta2* subtype in the modulation of dopamine release from rat striatal synaptosomes | |
| P478 | volume | 20 |
| Q58790106 | Acetylcholine Neurotransmitter Receptor Densities in the Striatum of Hemiparkinsonian Rats Following Botulinum Neurotoxin-A Injection |
| Q28344406 | Acute synaptic modulation by nicotinic agonists in developing cerebellar Purkinje cells of the rat |
| Q37086977 | Amitifadine, a triple monoamine re-uptake inhibitor, reduces nicotine self-administration in female rats |
| Q40645598 | Attentional effects of nicotinic agonists in rats |
| Q34340033 | Biochemical and functional properties of distinct nicotinic acetylcholine receptors in the superior cervical ganglion of mice with targeted deletions of nAChR subunit genes. |
| Q40413207 | Cellular responses to nicotinic receptor activation are decreased after prolonged exposure to galantamine in human neuroblastoma cells |
| Q64994574 | Characterization of nicotinic acetylcholine receptor-mediated [(3)H]-dopamine release from rat cortex and striatum. |
| Q35112780 | Cholinergic nicotinic receptors: Competitive ligands, allosteric modulators, and their potential applications |
| Q57125176 | Cholinergic regulation of mood: from basic and clinical studies to emerging therapeutics |
| Q40821290 | Chronic exposure to nicotine upregulates the human (alpha)4((beta)2 nicotinic acetylcholine receptor function. |
| Q42453415 | Chronic nicotine causes functional upregulation of ionotropic glutamate receptors mediating hippocampal noradrenaline and striatal dopamine release |
| Q30396291 | Cognitive deficits in schizophrenia: focus on neuronal nicotinic acetylcholine receptors and smoking |
| Q33833344 | Cyanobacterial Toxins of the Laurentian Great Lakes, Their Toxicological Effects, and Numerical Limits in Drinking Water |
| Q36063653 | Developmental regulation of nicotinic acetylcholine receptors within midbrain dopamine neurons |
| Q28345770 | Differential effects of chronic drug treatment on alpha3* and alpha7 nicotinic receptor binding sites, in hippocampal neurones and SH-SY5Y cells |
| Q44182701 | Differential regulation of nicotinic receptor-mediated neurotransmitter release following chronic (-)-nicotine administration |
| Q35699233 | Dissociation between duration of action in the forced swim test in mice and nicotinic acetylcholine receptor occupancy with sazetidine, varenicline, and 5-I-A85380. |
| Q28586513 | Distribution and pharmacology of alpha 6-containing nicotinic acetylcholine receptors analyzed with mutant mice |
| Q28363006 | Dose-related neuroprotective effects of chronic nicotine in 6-hydroxydopamine treated rats, and loss of neuroprotection in alpha4 nicotinic receptor subunit knockout mice |
| Q46402511 | Drug discrimination and neurochemical studies in alpha7 null mutant mice: tests for the role of nicotinic alpha7 receptors in dopamine release |
| Q52144163 | Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task. |
| Q43263931 | Effects of chronic drug treatments on increases in intracellular calcium mediated by nicotinic acetylcholine receptors in SH-SY5Y cells |
| Q47253869 | Efficient Enzymatic Routes for the Synthesis of New Eight-membered Cyclic β-Amino Acid and β-Lactam Enantiomers |
| Q48326327 | Ethanol consumption produces changes in behavior and on hippocampal alpha7 and alpha4beta2 nicotinic receptors |
| Q43882948 | Expression of neuronal nicotinic acetylcholine receptor subunit mRNAs within midbrain dopamine neurons |
| Q28288721 | From ligand design to therapeutic efficacy: the challenge for nicotinic receptor research |
| Q44185954 | Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum. |
| Q48451558 | In vivo neurochemical characterization of anatoxin-a evoked dopamine release from striatum |
| Q44235448 | Increased high-affinity nicotinic receptor-binding in rats exposed to lead during development |
| Q28346506 | Involvement of protein kinase C in the presynaptic nicotinic modulation of [(3)H]-dopamine release from rat striatal synaptosomes |
| Q35598427 | Knockout and knockin mice to investigate the role of nicotinic receptors in the central nervous system |
| Q73109552 | Lobeline inhibits nicotine-evoked [(3)H]dopamine overflow from rat striatal slices and nicotine-evoked (86)Rb(+) efflux from thalamic synaptosomes |
| Q28564628 | Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei |
| Q34498032 | Neurobiology of the nicotine withdrawal syndrome |
| Q34552613 | Nicotine addiction: the possible role of functional upregulation |
| Q34995021 | Nicotine and nicotinic receptors; relevance to Parkinson's disease |
| Q73109576 | Nicotine at concentrations found in cigarette smokers activates and desensitizes nicotinic acetylcholine receptors in CA1 interneurons of rat hippocampus |
| Q43940157 | Nicotinic acetylcholine receptors interact with dopamine in induction of striatal long-term depression. |
| Q73109562 | Nicotinic receptors co-localize with 5-HT(3) serotonin receptors on striatal nerve terminals |
| Q43846372 | Nornicotine, a nicotine metabolite and tobacco alkaloid: desensitization of nicotinic receptor-stimulated dopamine release from rat striatum |
| Q24625408 | Phantasmidine: an epibatidine congener from the ecuadorian poison frog Epipedobates anthonyi |
| Q43719666 | Potential regulation of nicotine and ethanol actions by alpha4-containing nicotinic receptors |
| Q36994843 | Specific α4β2 nicotinic acetylcholine receptor binding of [F-18]nifene in the rhesus monkey |
| Q90176817 | Stimulation of brain nicotinic acetylcholine receptors activates adrenomedullary outflow via brain inducible NO synthase-mediated S-nitrosylation |
| Q26863113 | Striatal cholinergic interneuron regulation and circuit effects |
| Q39414543 | Striatal cholinergic interneurons and Parkinson's disease. |
| Q35598396 | Studies of muscarinic neurotransmission with antimuscarinic toxins |
| Q51828811 | Substituted heteroaromatic compounds: effect on nicotine self-administration in rats. |
| Q28506626 | Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice |
| Q42158126 | Subunit composition of α5-containing nicotinic receptors in the rodent habenula |
| Q33973824 | Synthesis and nicotinic binding of novel phenyl derivatives of UB-165. Identifying factors associated with alpha7 selectivity |
| Q44628577 | The Allosteric Potentiation of Nicotinic Acetylcholine Receptors by Galantamine Is Transduced into Cellular Responses in Neurons: Ca2+Signals and Neurotransmitter Release |
| Q28972418 | The Chemistry and Pharmacology of Anatoxin-a and Related Homotropanes with respect to Nicotinic Acetylcholine Receptors |
| Q34156147 | The alpha7-nicotinic acetylcholine receptor and the pathology of hippocampal interneurons in schizophrenia |
| Q44519057 | The nicotinic alpha 4 beta 2 receptor selective agonist, TC-2559, increases dopamine neuronal activity in the ventral tegmental area of rat midbrain slices |
| Q36933882 | The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum |
| Q35964545 | Tobacco dependence and withdrawal: science base, challenges and opportunities for pharmacotherapy |
| Q42836220 | α4β2 nicotinic acetylcholine receptors in the early postnatal mouse superior cervical ganglion |
| Q35264378 | α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease |
Search more.